This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Invox Pharma Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Michael Dyson - Innovator in Antibody Molecules
Introduction
Michael Dyson is a notable inventor based in Sawston, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. His work focuses on creating innovative solutions that can have a profound impact on medical treatments.
Latest Patents
Michael Dyson holds a patent for antibody molecules that are capable of binding specifically to PD-L1. This patent also includes the development of antigen-binding fragments that can bind to PD-L1 and a second antigen-binding site. The methods of making and using these antibody molecules are also detailed in his patent, showcasing his expertise in this area.
Career Highlights
Michael Dyson is associated with Invox Pharma Limited, where he continues to work on advancing biopharmaceutical innovations. His career is marked by a commitment to improving therapeutic options through scientific research and development.
Collaborations
Michael collaborates with talented individuals such as Francisca Wollerton and Matthew Lakins. Their combined efforts contribute to the innovative projects at Invox Pharma Limited.
Conclusion
Michael Dyson's work in the field of antibody molecules exemplifies the importance of innovation in biotechnology. His contributions are paving the way for new medical advancements that can benefit many.